Testing a tool to improve discussions about kidney management for older patients
A Pilot Study of The CKM JumpStart Tool
This study is testing a new tool to see if it helps older patients with advanced kidney disease have better conversations with their doctors about managing their condition.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 76 (estimated) |
| Ages | 75 Years and up |
| Sex | All |
| Sponsor | University of Washington Academic / other |
| Locations | 2 sites (Seattle, Washington and 1 other locations) |
| Trial ID | NCT05753020 on ClinicalTrials.gov |
What this trial studies
This pilot study evaluates the CKM JumpStart Tool, designed to enhance communication between older patients with advanced chronic kidney disease (CKD) and their healthcare providers regarding conservative kidney management. The study will enroll 76 patients aged 75 and older, who will be randomized to receive either the CKM JumpStart Tool or usual care. Data will be collected at multiple time points to assess the feasibility and acceptability of the tool, focusing on the frequency of discussions about CKM. The goal is to determine if the tool leads to more meaningful conversations about treatment options.
Who should consider this trial
Good fit: Ideal candidates are English-speaking adults aged 75 and older with advanced CKD who are open to discussing their treatment options.
Not a fit: Patients currently receiving maintenance dialysis may not benefit from this study.
Why it matters
Potential benefit: If successful, this tool could significantly improve patient-provider communication and decision-making for older patients with advanced CKD.
How similar studies have performed: While the approach is innovative, similar studies focusing on communication tools in chronic disease management have shown promise.
Eligibility criteria
Show full inclusion / exclusion criteria
Patients Inclusion: * Adults aged ≥75 years * Advanced CKD as defined as having at least 2 outpatient measures of eGFR \<25 ml/min/1.73m2 separated by \>90 days in the prior year and with at least 1 eGFR measure \<20. * English-speaking * Receive care from a provider at UW Medicine or VA Puget Sound * Open to discussing their values and treatment options for kidney disease with their provider. Exclusion: * Unable to complete the informed consent process * Currently receiving maintenance dialysis Providers Inclusion * Their patient is a participant in the study. * Are a UW Medicine or VA Puget Sound provider or trainee. Exclusion • None
Where this trial is running
Seattle, Washington and 1 other locations
- VA Puget Sound Health Care System — Seattle, Washington, United States (Recruiting)
- University of Washington — Seattle, Washington, United States (Recruiting)
Study contacts
- Principal investigator: Susan P Wong, MD, MS — University of Washington
- Study coordinator: Olivia Gaughran, MA
- Email: ollyg@uw.edu
- Phone: 206-277-4376
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.